enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Carprofen - Wikipedia

   en.wikipedia.org/wiki/Carprofen

   A 100 mg Rimadyl tablet approximately 19 mm (0.75 in) wide by 8.6 mm (0.34 in) thick, as sold in the USA. Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the carbazole and propionic acid class that was previously for use in humans and animals but is now only available to veterinarians for prescribing as a supportive treatment for various conditions in animals. [1]

3. Polysulfated glycosaminoglycan - Wikipedia

   en.wikipedia.org/wiki/Polysulfated_glycosaminoglycan

   Polysulfated glycosaminoglycan (PSGAG), sold under the brand name Adequan, is an injectable drug for dogs and horses that is used to alleviate the limpness, pain, and lowered range of motion caused by arthritis. [2]

4. 29 Best Flea Medicines for Dogs Without Vet Prescription - AOL

   www.aol.com/entertainment/29-best-flea-medicines...

   29 Best Flea Medicine for Dogs Without Vet Prescription. Pupper Absorb. Penguin CBD Dog Oil. Amazon Basics Flea and Tick Topical Treatment. PetArmor Plus Flea and Tick Prevention for Dogs. K9 ...

5. The Best Generic Brands That Save You Money - AOL

   www.aol.com/best-generic-brands-save-money...

   Most consumers agree that buying generic rather than name-brand products is a good way to keep down costs. Find: 8 Companies Behind Costco's Kirkland Brand ProductsLearn More: How To Build Your...

6. Zoetis - Wikipedia

   en.wikipedia.org/wiki/Zoetis

   Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.

7. Popular dog arthritis medication Librela linked to pet ... - AOL

   www.aol.com/popular-dog-arthritis-medication...

   More than 3,600 cases of debilitating dog health problems caused by the medication were reported between January 2023 and March 2024, the FDA said in the cautionary letter, published Monday.